Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
3.99 USD
5%
Market Closed
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Net Change in Cash
|
Adaptive Biotechnologies Corp
Net Change in Cash Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Net Change in Cash
-$22.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Net Change in Cash
-$440m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Danaher Corp
NYSE:DHR
|
Net Change in Cash
-$348m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Net Change in Cash
-$19m
|
CAGR 3-Years
56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Agilent Technologies Inc
NYSE:A
|
Net Change in Cash
$497m
|
CAGR 3-Years
68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Net Change in Cash
$160m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
See Also
What is Adaptive Biotechnologies Corp's Net Change in Cash?
Net Change in Cash
-22.7m
USD
-22.7m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Net Change in Cash amounts to -22.7m USD.
What is Adaptive Biotechnologies Corp's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
17%
17%
Over the last year, the Net Change in Cash growth was -13%. The average annual Net Change in Cash growth rates for Adaptive Biotechnologies Corp have been 17% over the past three years .
You don't have any saved screeners yet
